Ozcelik, M. Et Al. 2016. The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.18, no.6 , 617-624.

Ozcelik, M., Odabas, H., Ercelep, O., Yuksel, S., Mert, A. G., Aydin, D., ... Surmeli, H.(2016). The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.18, no.6, 617-624.

Ozcelik, M. Et Al. "The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients," CLINICAL & TRANSLATIONAL ONCOLOGY , vol.18, no.6, 617-624, 2016

Ozcelik, M. Et Al. "The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.18, no.6, pp.617-624, 2016

Ozcelik, M. Et Al. (2016) . "The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.18, no.6, pp.617-624.

@article{article, author={M. Ozcelik Et Al. }, title={The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients}, journal={CLINICAL & TRANSLATIONAL ONCOLOGY}, year=2016, pages={617-624} }